Drug Type Small molecule drug |
Synonyms UK 315716 |
Target |
Action antagonists |
Mechanism GlyR antagonists(Glycine receptor antagonists), NMDA receptor antagonists(Glutamate [NMDA] receptor antagonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC17H12Cl2N6O3 |
InChIKeyYDYJCQIIFXPRMI-UHFFFAOYSA-N |
CAS Registry197077-52-4 |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Stroke | Preclinical | United Kingdom | - |





